ArticleExperimental dermatology2026
Revisiting Type VII Collagen Mislocalisation in Dystrophic Epidermolysis Bullosa Using High-Resolution Imaging.
Article in Experimental dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Type VII collagen (COL7), a major component of anchoring fibrils, is essential for dermal-epidermal adhesion and pathogenic variants in COL7A1, encoding COL7, cause dystrophic epidermolysis bullosa (DEB). In normal skin, COL7 is localised just beneath the lamina densa. In contrast, previous immunoelectron microscopy (IEM) studies of DEB skin with residual COL7 expression demonstrated aberrant localisation of COL7 above the lamina densa and hemidesmosomes of epidermal basal keratinocytes, possibly reflecting impaired secretion of defective COL7. However, conventional microscopy techniques lack sufficient spatial resolution to clearly visualise individual protein distributions and resolve this finding. Here, we revisit the abnormal localisation of COL7 using two higher-resolution approaches: structured illumination microscopy (SIM) and expansion microscopy (ExM). In normal human skin, the COL7 NC1 domain colocalised with type IV collagen (COL4), a surrogate marker of the lamina densa and was consistently detected beneath integrin α6 (ITGA6), a hemidesmosomal marker. In DEB skin with residual COL7 expression, COL7 was detected above ITGA6 within basal keratinocytes, recapitulating previous IEM observations. SIM quantitatively confirmed significant BMZ disorganisation in DEB, whereas ExM showed a consistent but non-significant trend, likely due to variability in expansion factors. These findings demonstrate that high-resolution fluorescence imaging can reproduce classic IEM observations of COL7 mislocalisation, suggesting its potential as a more accessible complementary approach for morphologic assessment of DEB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.